Principal Consultant  ·  Life Sciences

Brijesh
Setia

eCompliance & Validation Leader  ·  Global Patient Safety Systems
GxP / GVP  ·  FDA Inspection Readiness  ·  AI Governance

Helping regulated organizations adopt AI safely — without slowing down.
20+
Years in Life Sciences
230+
GxP Apps Transformed
$5M
FDA Consent Decree Exit
0
Critical FDA Findings
What I Do

Three things that define
strong eCompliance leadership.

🔬

Patient Safety Validation

CSV/CSA for GxP-regulated Patient Safety systems — Argus Safety, RxLogix, IVP Intake & Collect, TalkDesk, aMIR, Salesforce, and Artemis. Change control, SOP authoring, and end-to-end validation lifecycle management in PV-regulated environments.

🏛️

FDA Inspection Readiness

Consent decree remediation, inspection preparation, audit management, and CAPA closure across pharma, biotech, and medical device organizations. Consistent zero critical findings track record across FDA inspections, Internal Audits, and regulatory reviews.

🤖

Data & AI Transformation

Responsible AI governance frameworks and AI-powered validation automation within GxP-regulated environments. Bridging the gap between AI adoption speed and compliance rigor — enabling organizations to move fast without putting patients or audits at risk.

Career Highlights

20+ years of enterprise-scale
program delivery.

2010–12

$5M FDA Consent Decree Exit — American Red Cross

FSV & MSIT Lead for Blood Collection, Testing & Distribution ERP validation. Helped ARC exit 14+ years of FDA oversight in 2 years, leading a team of 25 validation SMEs across 3 national site events.

2020–24

VISiON CSA Transformation — Bristol Myers Squibb

Co-led enterprise-wide CSA transformation across 230+ GxP applications (BMS, Celgene, Juno) over 15 months. Weekly governance reporting to senior directors; monthly C-suite updates. Pioneered AI-assisted CSV documentation — ITVS Science Fair 2nd place.

2004–08

FDA Inspection — Zero Critical Findings, Fujifilm Medical

Represented QSS function alongside the IT Director in an FDA inspection. Achieved zero critical findings. Also led a full QMS rebuild — SOPs, templates, Master Inventory — from the ground up.

2012–17

Consent Decree Remediation — Johnson & Johnson

Independent Quality Lead on McNeil/J&J Consumer FDA consent decree remediation (Tylenol-related FDA 483). Delivered GOLD project SAP go-live across 3 phases with zero critical compliance issues.

2012

DIA Forum Publication

"REMS: Safeguarding Patients and Offering Strategic Opportunity." One of the earliest peer-reviewed analyses positioning REMS as both a patient safety compliance framework and a strategic business opportunity.

Credentials

Certifications & Education

Active Certifications
CISA CRISC CDPSE PMP SAPM
AI & Emerging Tech
AIGP — In Progress Ethics of AI · LSE AI in Pharma · MIT
Education
MBA · Binghamton / SUNY Advanced PM · Stanford PG Diploma · IMDR
Core Domains
GxP / GVP SOX 21 CFR Part 11 ISO 27001 NIST
Let's Connect

Navigating AI adoption
in a regulated environment?

I work with pharma, biotech, medical device, and CRO organizations to validate and govern complex regulated systems — so they can move fast without putting patients or audits at risk.